Accurate axillary staging by superparamagnetic iron oxide-enhanced MRI at 1.5 T with fat-suppression sequence as an alternative to sentinel node biopsy in breast cancer

Abstract
Dear Editor,
Funding Information
  • Meito Sangyo, Magnetic Health Science Foundation
  • Novartis Pharma
  • Daiichi Sankyo and Takeda Pharmaceutical